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ABSTRACT
The hepatitis delta virus (HDV) ribozyme is a self-
cleaving RNA enzyme essential for processing viral
transcripts during rolling circle viral replication. The
first crystal structure of the cleaved ribozyme was
solved in 1998, followed by structures of uncleaved,
mutant-inhibited and ion-complexed forms. Recently,
methods have been developed that make the task of
modeling RNA structure and dynamics significantly
easier and more reliable. We have used ERRASER
and PHENIX to rebuild and re-refine the cleaved and
cis-acting C75U-inhibited structures of the HDV ri-
bozyme. The results correct local conformations and
identify alternates for RNA residues, many in func-
tionally important regions, leading to improved R val-
ues and model validation statistics for both struc-
tures. We compare the rebuilt structures to a higher
resolution, trans-acting deoxy-inhibited structure of
the ribozyme, and conclude that although both in-
hibited structures are consistent with the currently
accepted hammerhead-like mechanism of cleavage,
they do not add direct structural evidence to the bio-
chemical and modeling data. However, the rebuilt
structures (PDBs: 4PR6, 4PRF) provide a more robust
starting point for research on the dynamics and cat-
alytic mechanism of the HDV ribozyme and demon-
strate the power of new techniques to make signif-
icant improvements in RNA structures that impact
biologically relevant conclusions.
INTRODUCTION
Hepatitis D is a human disease that, in acute and chronic
infections, can lead to increased chances of liver failure
and liver cancer. It is caused by a small virus-like particle
called hepatitis delta virus (HDV), which only infects pa-
tients who have a hepatitis B infection. HDV has a circular
RNAgenome of 1.7 kb that is replicated inside the host cells
into genomic and antigenomic (complementary to the origi-
nal genome)RNA.The replication is carried out by a rolling
circle mechanism that produces a linear RNA strand con-
taining multiple copies of the genome. These RNA strands
are cleaved into single genome-length strands (which later
ligate to form the circular genome), and this reaction also
separates and processes themRNA for the delta antigen, the
only protein encoded by theHDV genome. This cleavage re-
action is carried out by a stretch of 85 nucleotides (present
both in genomic and antigenomic RNA) that form the self-
cleaving RNA called the hepatitis delta virus ribozyme (1–
3). The catalytic activity of the HDV ribozyme is essential
for viral replication and viral particle assembly inside the
host cells. HDV-like ribozymes have also been found in a
variety of organisms and include the mammalian CPEB3
ribozyme found in the human CPEB3 gene known to play
a role in human memory (4–7). Therefore, it is important
to better understand the mechanism and structural basis of
the self-cleaving activity of the HDV ribozyme.
The cleavage reaction generates a cyclic phosphate at the
RNA product 3′ end and a hydroxyl group at its 5′ end, con-
sistent with a nucleophilic attack on the scissile phosphate
by the 2′ hydroxyl group of the previous residue (3). Either
divalent or monovalent cations are required for the cleav-
age reaction to occur; however, the reaction rate in saturat-
ing Mg2+ is ∼3000 times higher than the reaction rate in 1
M Na+ (8,9). In addition, residue C75 (C76 in the antige-
nomic ribozyme) is essential for the cleavage reaction, and
mutating C75 to any other base, especially uracil or gua-
nine, inhibits the reaction (10–12). The 2.3A˚ resolution crys-
tal structure of the genomic cleaved HDV ribozyme (13) re-
vealed that C75 is located in the active site and near the 5′
hydroxyl, providing evidence that RNA residues can par-
ticipate in general acid-base catalysis (a characteristic that
was previously believed to be specific to proteins), a notion
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also supported by a study linking C75 to proton transfer
(14). However, it is very difficult to distinguish unambigu-
ously between a general-acid and general-base mechanism
biochemically, and evenmore so structurally, and hence var-
ious studies have led to conflicting conclusions about the
function of C75 in the cleavage reaction. Both the 2.3A˚
crystal structure of the cleaved ribozyme (13) and experi-
ments using imidazole to restore cleavage in a C75Umutant
ribozyme (15) suggested that C75 acts as a general base.
Structures of the genomic cis-acting uncleaved ribozyme
at resolutions ranging from 2.2 to 3.4A˚, inhibited with a
C75U mutation (16), also supported the general-base role
for C75, with a proposed hinge rotation about the O3′-P
bond to orient C75 and 2′ hydroxyl for the cleavage reac-
tion. Other biochemical results supported a general-acid
role for C75 (8) by demonstrating mutant ribozyme cleav-
age in a reaction buffer that substitutes for C75 and acts as
a proton donor (17). Molecular dynamics simulations with
the C75U-inhibited structure as a starting model also pro-
vided conflicting results. One study reported spontaneous
rotation of the residue at position -1 (cleavage is between
residues -1 and 1) to support the general-base role for C75
(18), and their efforts to simulate a general-acid role for C75
failed. Another study reported a similar spontaneous rota-
tion, but supported the general-acid role for C75 (19).
The most compelling evidence for a general-acid role for
C75 was provided by mutations and single-atom substitu-
tions on the catalytic pyrimidine and the leaving group,
which associated theN3 atom of C75 with the leaving group
(20). Additional support came from a later 1.9A˚ resolution
crystal structure of the trans-acting HDV ribozyme (21),
with the cleavage reaction inhibited by introducing deoxyri-
bonucleotides at the scissile and neighboring position on
the substrate strand. No significant electron density was ob-
served for the single nucleotide upstreamof the cleavage site.
Therefore, to propose a model for the catalytic mechanism,
the hammerhead ribozyme cleavage site (22) was superim-
posed on that of the HDV ribozyme, implying a similar re-
action mechanism. This proposal is also consistent with a
recent computational study that analyzes metal ion contri-
butions to the C75 general-acid mechanism (23). Further
biochemical studies comparing the pH-rate profiles of the
wild-type and mutant ribozyme (24) and employing phos-
phorothioates at the scissile phosphate (25) also supported
the general-acid role for C75. The current consensus in the
field is that C75 acts as a general acid (26), with the hydrated
metal ion acting as the general base.
One aspect which complicates resolving the catalytic
mechanism of the HDV ribozyme is the substantial dif-
ferences between constructs for the cleaved, the C75U-
inhibited and the deoxy-inhibited crystal structures (com-
pared in Figures 1 and 2), making clean interpretations dif-
ficult. Because the P4 stem-loop details are non-essential,
crystallization was promoted by replacing its end (bottom
of Figure 1) with known interaction motifs: the target se-
quence of the RNA-binding domain of spliceosomal pro-
tein U1A (U1A-RBD) in the early structures, and a GNRA
tetraloop in the deoxy-inhibited structure. The sequence
gap in the trans-acting deoxy-inhibited form shifts the P1
and P2 stems somewhat (green spline, Figure 1), and it also
contains an additional base pair in the P2 stem.Of necessity,
Figure 1. Superposition of the three crystal structures of the HDV ri-
bozyme: rebuilt cis-acting C75U-inhibited (PDB ID: 4PRF in gold), re-
built cleaved (PDB ID: 4PR6 in blue) and trans-acting deoxy-inhibited
(PDB ID: 3NKB, ribozyme in green, substrate strand in light green).
Active-site metal ions for the two inhibited structures are also shown in
corresponding colors. The region surrounding the metal ions forms the
active site.
significant changes must be made to the molecule in order
to prevent catalysis, especially on the crystallographic time
scale. In addition, the early structures have areas of implau-
sible RNA conformations around the active site. Now we
are able to relieve that last problem.
Determining crystal structures of RNA, especially ob-
taining full-detail accuracy for the backbone with its many
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Figure 2. Sequences of the three HDV ribozyme crystal structures, aligned with the full-length ribozyme. The colors of the PDB IDs correspond to the
colors of the splines in Figure 1. Residues discussed individually in the paper are highlighted in cyan and are in bold. Part of the P4 stem-loop was replaced
by residues shown in smaller italics (U1A hairpin sequence motif in 1CX0/4PR6 and 1VC7/4PRF, and GAAA loop in 3NKB) to aid crystallization. These
residues (146–159 in 1CX0/4PR6 and 1VC7/4PRF, 50–53 in 3NKB) do not have a corresponding sequence number in the full-length HDV ribozyme.
parameters per nucleotide (27,28), is in general a challeng-
ing task. Using recent technical developments not available
for the early structures, both manual and automated tools
have been developed that make the process much easier and
more accurate. A set of 54 valid RNA backbone conform-
ers, a reliable way to assign ribose pucker from clear ob-
servables in the electron density, and then use of pucker-
specific target values for refinement (29–31) first enabled
RNARotator (32) and RCrane (33) tools for manual fitting
and the RNABC tool for automated backbone correction
(34). Most importantly, there is now an automated, exhaus-
tive local sampling system, called ERRASER (35–37) that
extends and combines capabilities in the Rosetta (38), Mol-
Probity (39) and PHENIX (29) software packages to cor-
rect nearly all local geometrical, conformational and steric
errors in RNA structures. In the present study, we used the
above new techniques to rebuild and re-refine the cleaved
(PDB ID: 1CX0) (13) and the cis-acting C75U-inhibited
(PDB ID: 1VC7) (16) structures of theHDV ribozyme. That
process improved structural models for the HDV ribozyme
active site and identified alternate conformations that fit
the electron density better for some residues. The rebuilt
structures have been deposited with the Protein Data Bank
IDs of 4PR6 (cleaved) and 4PRF (C75U-inhibited). We
also compare these rebuilt structures with a higher resolu-
tion structure of the trans-acting deoxy-inhibited ribozyme
(PDB ID: 3NKB) (21) and highlight the similarities and the
differences between them. Overall, our changes and correc-
tions alter some of the biological interpretations about the
catalytic mechanism that were based on the original struc-
tures, and our comparisons identify the lack of direct struc-
tural evidence for the position of upstream nucleotides pre-
ceding the cleavage reaction.
MATERIALS AND METHODS
Structure validation
To assess model-to-data match, we used R, Rfree and dif-
ference electron density. To assess model quality, we used
MolProbity (39,40) (version 4.1), a structure-validationweb
service that evaluates many features of RNA and protein
models, or the equivalent functionality within PHENIX
(29,41). MolProbity adds hydrogen atoms to the model,
analyzes all-atom contacts and reports impossible steric
clashes (atomic overlaps of >0.4A˚) both individually and
as ‘clashscore’. Any bond-lengths and bond-angles that de-
viate by >4σ from the expected values are flagged as out-
liers. Validation of protein residues includes evaluation for
Ramachandran outliers, deviations in C position and side-
chain rotamer outliers.
MolProbity’s RNA-specific evaluations include analysis
of RNA ribose sugar pucker and RNA backbone conform-
ers. The ribose ring in RNA almost always has one of two
puckers, C3′-endo or C2′-endo, with the mean value of the 
dihedral angle (C5′-C4′-C3′-O3′) being 84 and 147◦, respec-
tively. To validate the modeled pucker for the ribose ring
of a given residue, the value of the  dihedral angle is com-
pared to the length of the perpendicular dropped from the 3′
phosphate to the extended line of the glycosidic bond vector
(31). If the dihedral and the length of the perpendicular in-
dicate different puckers, then the modeled pucker is almost
certainly incorrect and is flagged as an outlier. In PHENIX,
this diagnosis is used to set appropriate target values for the
ribose ring and backbone dihedral angles, improving refine-
ment behavior.
The RNA sugar-phosphate backbone, with its many de-
grees of freedom, has been shown to be rotameric (27),
and is most likely to adopt one of the known 54 back-
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bone conformers (30). These conformers represent the fa-
vorable conformations of the sugar-to-sugar unit of RNA
backbone called a suite. Each backbone conformer has a
two-character name; for example, 1a represents the con-
formation of the RNA backbone in a standard A-form
helix. For RNA backbone validation in MolProbity and
PHENIX, automated backbone conformer assignment is
done by Suitename, and if a suite does not belong to any
of the 54 backbone conformers, it is flagged as an outlier,
denoted as !!. For details on validation methods, refer to
the Supplementary Information section S2.
Structure rebuilding and correction
We used several tools available to rebuild and correct
the RNA chain. The most powerful tool is Enumerative
Real-space Refinement ASisted by Electron density under
Rosetta, or ERRASER (35,36). Given a PDB file, ER-
RASER keeps only the RNA residues and rebuilds any
with problems in a three-stage procedure. To begin with,
ERRASER minimizes all torsion angles and all back-
bone bond-lengths and bond-angles in the model using
the Rosetta high-resolution energy function (38), which in-
cludes an electron density correlation score to ensure that
the new model is consistent with the experimental data.
Next, PHENIX’s (29) MolProbity-style RNA validation
tools are used to identify geometry, pucker and unrecog-
nized backbone conformations in the minimized model (see
previous section on structure validation). These residues,
as well as residues with large rms deviation (>2A˚) between
their original position and the minimized position, are then
rebuilt one at a time through single-nucleotide stepwise as-
sembly (SWA), an ab-initiomethod of building each residue
by enumerating many conformations covering all build-up
paths (42). SWA is alternated with Rosetta ‘relax’ refine-
ment (38), usually for three cycles. After the rebuilding pro-
cess, the new model is minimized again. ERRASER can
also be used to rebuild a single residue at a time, in which
case it returns the top 10 possible distinct conformations.
For the purposes of this paper, we used both the general and
single-residue rebuilding capabilities of ERRASER avail-
able in Rosetta3.5 (38).
For manual fitting and correction of the RNA structure,
we used RCrane (33), a plugin available in Coot version
0.6 (43), and the RNA Rotator tool available in the visual-
ization software KiNG (32). RCrane uses RNA backbone
pseudo dihedrals (to classify the relative position of the C1′
atom and the phosphate group) as input and builds the rest
of the backbone atoms in the electron density, keeping the
inputs fixed. RNARotator allows the user to choose a back-
bone suite to manually edit all seven backbone and two 
dihedral angles. It also provides a list of the 54 backbone
conformers for the user to choose from and interactive feed-
back on many validation scores; for instance, all-atom con-
tact analysis and quality of the backbone conformer is pro-
vided in real-time.
For protein corrections, we used the side-chain rotator
tool in KiNG, which allows the user to try a specific ro-
tamer from an updated version of the penultimate amino
acid rotamer library (44) and then adjust the side-chain 
dihedral angles, with interactive feedback for both all-atom
contacts and rotamer quality.We also used the backrub tool
(45) available in KiNG tomanually adjust the protein back-
bone in certain cases where moving the side chain alone was
not sufficient to fix the error. Similar to RNARotator, both
these tools carry out all-atom contact analysis and other
validation in real-time for interactive feedback.
Note that the initial process of rebuilding was done from
the crystallographic data and generic knowledge of RNA
and protein structure. Structure comparisons and interpre-
tation in terms of the specific functional issues for this ri-
bozyme were then done jointly with the Doudna and Cate
groups, followed by the necessary further investigations.
Structure refinement
The structures were refined against the diffraction data,
both before and after each stage of the rebuilding process,
with the PHENIX crystallography software, version 1.8.4-
1496 (29,41). Coordinates, individual B-factors and occu-
pancies were refined, the weight of geometry versus diffrac-
tion data terms was optimized and target parameter values
were ribose-pucker specific.
Residue numbers
Figure 2 shows the sequences in the three crystal struc-
tures (cis-acting C75U-inhibited 1VC7/4PRF, cleaved
1CX0/4PR6 and trans-acting deoxy-inhibited 3NKB)
aligned with the sequence of the full-length HDV ribozyme.
In this paper, all RNA residues are numbered according
to the full-length ribozyme, unless otherwise specified. Re-
fer to the figure for the corresponding PDB coordinate-file
residue numbers.
RESULTS
The correction process and its conclusions are described
from the more minor and straightforward to the more ex-
tensive and unusual. They are then discussed in terms of
their functional relevance.
Rebuild of the cleaved 1CX0 structure
The 1CX0 crystal structure of the HDV ribozyme self-
cleaved product (13) was one of the earliest ribozyme struc-
tures ever solved, at 2.3A˚ resolution, with R = 24.6% and
Rfree = 27.9% as calculated by PHENIX. Notably, it ex-
ploited the ability ofU1A-RBDprotein to form crystal con-
tacts, thereby facilitating crystal growth, by removing part
of the P4 stem-loop of the genomic HDV ribozyme and re-
placing it with a U1A hairpin. Over 15 years later, MolPro-
bity statistics can now diagnose many potential improve-
ments in local model detail. For the RNA chain, there are
8/72 ribose pucker outliers, 16/72 unrecognized backbone
conformations (denoted by !!) and 28 bond angles with devi-
ations>4σ . For the overall structure, the clashscore is 13.8,
which is better thanmost at that resolution (83rd percentile)
but could be improved along with other corrections.
By using a combination of PHENIX refinement, ER-
RASER corrections and hand rebuilding in Coot and in
KiNG, we made multiple changes to the model that im-
proved its agreement with the experimental data and its
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Figure 3. U23 and Mg2+ of the cleaved structure with Fo-Fc difference density at 3.5σ contour level. Here and in later figures, the blue and orange mesh
correspond to positive and negative difference density respectively, hydrogen bonds are shown as green dotted pillows, steric clashes as hotpink spikes,
ribose pucker outliers as magenta crosses, and bond-length or bond-angle outliers as springs or fans (blue if too small, red if too large). (a) The base and
backbone of U23 in the original structure (1CX0), with the modeling errors highlighted. (b) Alternate conformations of U23 in the rebuilt structure (4PR6),
with the backbone (gold), base (orange) and metal ion (brown) for the new conformation. All the modeling errors are corrected, and the difference density
peaks have disappeared.
Figure 4. G25 and U20 in the cleaved ribozyme structure with Fo-Fc difference density at 3.5σ contour level. The hydrogen-bonded heavy atoms of U20
and G25 are highlighted as atom-colored balls. (a) Original structure (1CX0) and original density. (b) Reverse GU wobble base pair in the rebuilt structure
(4PR6). U20 now makes hydrogen bonds with G25, and the positive difference density peak has disappeared.
MolProbity statistics. All geometry and ribose pucker out-
liers identified by MolProbity were corrected as a result of
PHENIX refinement and rebuilding using ERRASER. The
pucker corrections were particularly impressive; hand re-
fits and the use of RNABC (26) were initially successful in
correcting only one of these ribose puckers, PDB residue
152, refitting the C3′-endo pucker as C2′-endo, while the
other seven ribose puckers were each corrected to C2′-endo
pucker only by using ERRASER. Correcting these ribose
pucker outliers resulted in four suites (sugar-to-sugar unit
of the RNA backbone used for validation) changing to
recognized backbone conformers. In total, 12 suites were
changed from the original model, some moved from !! to a
recognized backbone conformer, and somemoved from one
conformer to another. Overall, the number of unrecognized
backbone conformations reduced from 16 to 9 (see Supple-
mentary Table S1).
U23 alternate conformation. The electron density around
residue U23 (Figure 3(a)) suggests a possible alternate con-
formation with the base facing the opposite direction to
that of the original model. Indeed, cleavage-inhibited crys-
tal structures show positionsmore like this second alternate.
Given this evidence, we fit a second alternate, based loosely
on PDB residues U23-C24 in 1SJ3 (16) and in 3NKB. The
alternate was created in Coot and rebuilt in ERRASER be-
fore PHENIX refinement. After refinement, it was rebuilt
in ERRASER a second time, using the single-residue re-
build option. The end result of this process has the density
previously occupied by the Mg2+ in 1CX0 now occupied
by the alternate conformation base (Figure 3(b)), with the
N1 in nearly the same place as the original magnesium. A
closer look at the new density showed that the alternate (alt
A) should also have Mg2+ bound to the phosphate oxygen
atoms of C24, approximately equivalently to Mg2+ bound
to the original model’s (alt B) conformation. Refinement
shows this pair of alternates to fit the data well, lowering
bothR andRfree. Occupancy refinement assigns alternate A
and alternate B 0.64 and 0.36 occupancy, respectively. Nei-
ther alternate is a recognized backbone conformer, but they
have no clashes or other outliers to show them invalid rather
than just rare.
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Table 1. MolProbity statistics for the original cleaved structure (PDB ID: 1CX0) and its rebuilt version (PDB ID: 4PR6)
The rebuilding process improved the clashscore from 83rd percentile to 100th percentile within its resolution range (2.30 ± 0.25A˚). Here and in Table. 2,
the ‘traffic light colors’ highlight the good (green), marginal (yellow) and bad (red) validation statistics. The total number of RNA bonds and angles is
larger in the rebuilt structure as it includes alternate conformations. See Supplementary Information (section S2) for details on structure validation.
G25:U20 reverse wobble base pair. Biochemical studies
(10) and the structure of the deoxy-inhibited ribozyme
3NKB indicated a reverse wobble base pair between G25
and U20. In the original 1CX0 structure (Figure 4(a)), the
bases of this potential pair are too far apart for hydrogen
bonding, and a positive difference density peak is seen near
U20. The backbone of U20 forms two hydrogen bonds: one
with the backbone of C22, and another weak one with C75,
but C22 clashes with bothU20 andC75. By using the single-
residue version of ERRASER, we were able to create a new
model for U20 that now forms the reverse-wobble hydrogen
bonds, gets rid of the difference density peak (Figure 4(b))
and fixes the C22 clashes, resulting in a full set of hydrogen
bonds matching those present in 3NKB. Improving the GU
base pair geometry also helped uncover a water molecule
that stabilizes tertiary interactions between the backbones
of C21, G62 and C63.
Overall, the rebuilt cleaved structure does not have any
geometry or ribose pucker outliers, and has fewer unrecog-
nized backbone conformations. The clashscore is reduced
to 0.75, placing the new structure in the 100th percentile
for its resolution range. The final R = 19.85% and Rfree =
24.08%, improved by 4.75 and 3.82%, respectively. Table 1
shows the complete MolProbity statistics for the original
(PDB ID: 1CX0) and the rebuilt structure (PDB ID: 4PR6).
Supplementary Figure S1 shows the improvement in outlier
markup on the 3D structure, and Supplementary Table S1
lists all backbone conformers and their ‘suiteness’ quality.
Rebuild of the cis-acting C75U-inhibited 1VC7 structure
To prevent catalysis in the crystal structure of the HDV ri-
bozyme, the catalytic residue C75 was mutated to a uracil.
The structure of this catalytically inactive mutant was
solved in the presence of a variety of metal ions that bind
to the active site. The structure with a strontium ion in the
active site (PDB ID: 1VC7) (16) contains, and shows, two
additional residues upstream of the cleavage site (the ‘up-
stream nucleotides’) as compared to the cleaved structure:
adenine at position -2 and uracil at position -1, with the
cleavage site between residue -1 and 1 (Figure 2).
The C75U-inhibited structure 1VC7 was solved at 2.45A˚
resolution and has R = 23.91% and Rfree = 26.40%, as cal-
culated by PHENIX with anisotropic B factors from the
original TLS refinement. It has a clashscore of 21.7, 61st
percentile for its resolution range, and the bound U1A-
RBD protein has a 95th percentile on MolProbity score.
The RNA chain has 12/74 ribose pucker outliers, 23/74 un-
recognized backbone conformations and six bond-length
and 29 (1%) bond-angle outliers >4σ , three of which are
>10σ .
After several cycles of automated rebuilding using tools
described before, evaluation of their output, and sporadic
manual rebuilding, alternated with rounds of refinement in
PHENIX, the structure was significantly improved. All ge-
ometry and ribose pucker outliers were corrected, including
10 ribose puckers that were misfit as either C3′-endo or O4′-
endo and now corrected to C2′-endo. The pucker correc-
tions led to significant changes in the backbone conform-
ers for a number of suites; 11 suites changed from !! to a
recognized backbone conformer. The total number of un-
recognized backbone conformations was reduced from 23
to 11 (see Supplementary Table S2). The following sections
describe the specific changes most significant for the HDV
ribozyme structure and function.
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Figure 5. Base and backbone of residue A16 for the C75U-inhibited structure, with 2Fo-Fc electron density at 1σ contour level. The hydrogen-bonded
heavy atoms of the base of A16 are highlighted as atom-colored balls. Here and in later figures, hydrogen bonds are shown as green dotted pillows and
clashes as hotpink spikes. (a) A16 in the original structure (1VC7) and original density. The base of A16 clashes with a water molecule (peach ball). (b) The
two alternate conformations for A16 in the rebuilt structure (4PRF) and new density.
Figure 6. G25:U20 base pair and themetal ion (gray ball) in theC75U-inhibited structure in 2Fo-Fc electron densitymap at 1σ contour level. The hydrogen-
bonded heavy atoms of G25 and U20 are highlighted as atom-colored balls. Here and in later figures, ribose pucker outliers are shown as magenta crosses.
(a) Hoogsteen-WC base pair in the original structure (1VC7) and original density. Both G25 and U20 are ribose pucker outliers. (b) Reverse wobble base
pair in the rebuilt structure (4PRF) and new density. Both ribose pucker outliers are corrected.
Alternate conformations for A16. Figure 5(a) shows the
model and electron density for residue A16 in the origi-
nal structure, which has a water molecule clashing with the
base. Visual examination of the density suggested that a dif-
ferent conformation of the base would fit the density bet-
ter, along with deletion of the water molecule. Indeed, the
single-residue rebuild option in ERRASER modeled this
conformation, although it results in a net loss of one hy-
drogen bond. The modeling of either conformation alone
gave a positive difference density peak, but using both con-
formations together as alternates (Figure 5(b)) eliminates
the difference density and matches the 2Fo-Fc density bet-
ter for both base and backbone. Both alternates occupy the
site equally, with the original conformation (alt A) refined
to 0.51 occupancy and the new conformation (alt B) to 0.49
occupancy. A16 is involved in aWatson-Crick AU base pair
and is located at the end of helix P2, which stacks co-axially
on helix P3. This location at the helix end makes it plausible
that this canonical AU base pair is somewhat destabilized
and can open and switch to an alternate conformation.
Flipping of G25 to form a reverse GU wobble base pair.
In the original structure, residue U20 interacts with the
Hoogsteen edge of residue G25 forming only one hydrogen
bond, and the RNA backbone model near G25 contains
steric clashes and ribose pucker outliers (Figure 6(a)). ER-
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Figure 7. The active site of the C75U-inhibited ribozyme, with the catalytic metal ion (gray ball). The gold balls highlight the oxygen atoms in the metal
ion neighborhood, and the dotted lines indicate metal ion interactions. Here and in later figures, bond-length outliers are shown as red and blue spirals,
and bond-angle outliers are shown as red and blue fans. (a) Original structure (1VC7). The active site has a number of modeling errors. (b) The rebuilt
structure (4PRF) active site, with all modeling errors corrected.
Figure 8. The position of the upstream nucleotides (A-2 andU-1) in the active site of the C75U-inhibited structure in 2Fo-Fc electron densitymap (contour
levels 1σ as gray mesh, 3σ as purple mesh). (a) Original structure (1VC7) and original density. Modeling errors are highlighted. Suite 1 is an unrecognized
backbone conformation (!!). (b) The rebuilt structure (4PRF) and new density. All modeling errors are corrected and suite 1 is now 1g.
RASER fixed the errors in the RNA backbone and, despite
our exerting no direct control over the arrangement of the
G25:U20 base pair, flipped the G25 residue, replacing the
original Hoogsteen base pair by a reverse GU wobble base
pair with two hydrogen bonds (Figure 6(b)). The electron
density at this residue is very weak, especially for the back-
bone, and the base density is not clear enough to differen-
tiate between the new and old conformations. Fitting both
as alternates, or reducing the occupancy of the reverse wob-
ble, worsened either the R values or the clashscore, and was
therefore not accepted.
Active site corrections. Inspecting the active site in the
original 1VC7 structure revealed bad geometry, steric
clashes and ribose pucker outliers (Figure 7(a)). The active
site after rebuilding, with no clashes, geometry or pucker
outliers, is shown in Figure 7(b). The important corrections
made are discussed individually below.
The self-cleaving reaction of the HDV ribozyme depends
on the catalytically active metal ion bound to the active site.
Figure 7(a) and (b) show the metal ion (strontium here)
and the nearby oxygen atoms in the original and rebuilt
active site, respectively. The O2 of U20 and O4 of U75
are unambiguously close ligands and do not move signif-
icantly. The OP2 of C22 stays at about 5A˚ distance and
points toward the metal. The OP1 of U23 shifts closer,
to 3.6A˚. The other nearby oxygen atoms are on residues
that changed conformation in the rebuilding. O5′ of G1
and OP2 of U -1 move away from the metal ion by almost
1A˚; at >6A˚ away, we do not consider them as interacting.
But now OP2 of G1 (pro-Rp oxygen of the scissile phos-
phate) is unambiguously available for interaction with the
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Table 2. MolProbity statistics for the original C75U-inhibited structure (PDB ID: 1VC7) and its rebuilt version (PDB ID: 4PRF)
The rebuilding process improved the clashscore from 61st percentile to 100th percentile within its resolution range (2.45 ± 0.25A˚).
metal ion at 4.2A˚, along with O6 of the flipped G25 that
now faces the metal ion at 4.1A˚ (atom names according to
the Recommendations of the IUPAC-IUB Joint Commis-
sion on Biochemical Nomenclature available at http://www.
chem.qmul.ac.uk/iupac/misc/pnuc2.html). Overall, the re-
built structure has six oxygen atoms with distances <5A˚
from the metal ion. Active-site waters are not clearly visible,
so it is difficult to evaluate the network of ligands. Supple-
mentary Table S3 gives distances between the metal ion and
the neighboring oxygen atoms in both the original and the
rebuilt structure.
The upstream nucleotides in the original structure, and
especially the critical backbone between U -1 and G1, show
steric clashes, geometry outliers and a too-short (clashing)
hydrogen bond between the base of U -1 and the backbone
of C3 (Figure 8(a)). The improved model of the upstream
nucleotides is shown in Figure 8(b). The N3 of U -1 and the
non-bridging OP2 phosphate oxygen of C3 are now at an
optimal hydrogen bonding distance. Suite U -1 is no longer
an  dihedral angle outlier and has an internal hydrogen
bond, and suite G1 moves from !! to 1g. An even better vi-
sual density fit for the upstream nucleotides resulted in a
0.3%higherRfree andwas deemed unacceptable (see Supple-
mentary Figure S3), thus leaving the backbone for A -2 and
phosphate of U -1 somewhat less well fit to the density than
the original structure. In compensation, however, the base
for A -2 moves into electron density in the rebuilt model.
The final model of the two upstream nucleotides, although
not fit or refined with alternate conformations, shows elec-
tron density accounting for perhaps 80% of full occupancy,
so the C75U mutation indeed succeeded in producing an
uncleaved structure. The backbone suite between U -1 and
G1 is now fit very satisfactorily, but the U -1 O2′ is still 9A˚
from the metal, and the position and orientation of the scis-
sile bond is even less appropriate for catalysis than in 1VC7.
Because of the corrections made to the backbone of U75
and nearby residues, the position of the base U75 is slightly
shifted in the rebuilt structure; it now more closely resem-
bles the consensus position found in the related series of
structures (16). Note that coordination of the metal ion by
O4 of U75 would not be possible in the wild-type ribozyme,
since the exocyclic amino group of a cytosine is present at
this position as opposed to the keto oxygen of the uracil.
This fact, as well as comparison with the deoxy-inhibited
structure (3NKB) and single-atom modifications at residue
75 (20), suggests that the specific position of the mutated
U75 in this uncleaved structure is probably not biologically
relevant and the mutation may have prompted a change in
the upstream nucleotide conformation as well (see Discus-
sion).
Overall, the rebuilt structure has no geometry or ribose
pucker outliers, and the number of unrecognized backbone
conformations is reduced. The clashscore improved dra-
matically, from 21.8 to 0.76, placing the rebuilt structure at
100th percentile for its resolution range. The rebuilt struc-
ture was refined with two TLS groups, one for the RNA
chain and one for the protein chain, and has R = 19.80%
and Rfree = 25.13%, an improvement of 4.11 and 1.27%, re-
spectively. Table 2 shows the completeMolProbity statistics
for the original (1VC7) and the rebuilt structure (4PRF).
Supplementary Figure S2 shows the improvement in outlier
markup on the 3D structures, and Supplementary Table S2
lists all backbone conformers and their ‘suiteness’ quality.
Protein corrections
Crystallization of the cleaved and the C75U-inhibited struc-
tures was promoted by using the U1A-RBD protein as a
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Figure 9. Arg47, Glu19 and nearby water molecule (peach ball) in the protein chain of the C75U-inhibited structure in the 2Fo-Fc electron density map
at 1.2σ contour level. The hydrogen-bonded heavy atoms of Arg47 and Glu19 are highlighted as atom-colored balls. (a) mmm180 rotamer of Arg47 in the
original structure (1VC7) clashes with both the water and the backbone of Glu19. (b)mtp180 rotamer of Arg47 in the rebuilt structure (4PRF) now makes
hydrogen bonds with both the water and the backbone of Glu19.
crystallization module. It was shown that replacing part of
the P4 stem-loop by the U1A binding sequence does not
alter ribozyme cleavage activity in the presence or absence
of U1A-RBD. Although the bound protein is irrelevant to
catalysis, correction of model errors there helps improve the
map elsewhere and the overall fit of the model to the exper-
imental data, as reflected in both R and Rfree. Corrections
to the U1A-RBD part of the structure were further vali-
dated by comparison with a higher resolution structure of
the isolated U1A-RBD protein bound to its cognate RNA
sequence (1.92A˚, PDB ID: 1URN) (46).
Minor shifts to fix steric clashes. Our main interest is in
making large corrections when the model is fit into the
wrong local energyminimum.Fixing a clash or other outlier
by small coordinate shifts is not important in itself and may
not survive subsequent refinement. However, the process of
trying such shifts is very important in order to determine
that the outlier is not a symptom of a larger problem.
The Asn9 side chain in 1VC7 clashes with the adjacent
backbone. Small changes in its side-chain dihedrals, plus a
small backrub shift (45) were enough to alleviate the clash.
The new conformation is further validated by 1URN and
1CX0/4PR6.
The Arg83 guanidinium in 1CX0 has a large steric clash
with the well-fit O2 of PDB residue U150, persisting de-
spite other improvements to the local structure. We used
the side-chain rotator in KiNG to tweak the  2 and  3 an-
gles to move Arg83 away from U150, and the new position
held through refinement. Arg83 in 1URN does not bind the
RNA, so its conformation cannot be compared.
Side-chain rotamer corrections. In 1VC7, the Arg47 side
chain clashes with the well-fit carboxyl group of Glu19 and
a nearbywatermolecule (Figure 9(a)).We flipped the guani-
dinium group over, changing the rotamer from ‘mmm180′ to
‘mtp180′ (m, p and t mean minus, plus and trans  angles).
The new rotamer now fits the density better, forms hydro-
gen bonds with both Glu19 and the water (Figure 9(b)) and
was found also to match 1URN.
The Leu69 in both 1CX0 and 1VC7 clashes with lo-
cal backbone, and is also a rotamer outlier in 1CX0. Re-
finement, alone, merely nudged clash and rotamer scores
just past the cutoff values (better for clashes, worse for ro-
tamers), with no significant net improvement. In contrast,
changing to the ‘tt’ rotamer and then refining removes both
clashes entirely, puts the  angles in a highly favored range
and matches the 1URN conformation.
In 1CX0, Ile33 clashes with the neighboring Phe34. Clear
positive and negative density peaks suggested a ‘pt’ rotamer
rather than the original ‘mp’ rotamer, which would then
match 1VC7/4PRF. After the rebuild and refinement, the
clash and the positive density are gone altogether and the
negative density has mostly disappeared. This new confor-
mation does not match the one found in 1URN, but that
one itself has a clash, so it is unclear whether or not they
really differ.
MSe72 in 1CX0 is originally fit as a ‘mmt’ rotamer, but
the HE1 atom has a very large clash with the Arg36 side
chain, which is also a rotamer outlier. The difference density
showed a strong peak in the ‘mmm’ rotamer position, which
would match both 1VC7/4PRF and 1URN. However, this
position clashedwith the previouslymodeled Ile33 position,
which had to be refit first (as described above). We initially
fit MSe72 with both alternate conformations, due to the ex-
tent of observed difference density in the area, but as the
local model improved with further corrections, it became
clear that modeling only the ‘mmm’ rotamer was necessary
to fit the density. Modeling just this refit rotamer improved
Rfree by >0.25% and allowed Arg36 to move into a valid
rotamer conformation.
DISCUSSION
Position of upstream nucleotides during the cleavage reaction
A defining characteristic of HDV-like ribozymes is the lack
of sequence conservation for the upstream nucleotides (4,6).
In addition, the C75U-inhibited structure showed an ab-
sence of any base-pairing interactions for the upstream nu-
cleotides. As a result, the upstream nucleotides are some-
what disordered in the crystal structure, showing nearly full-
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occupancy 2Fo-Fc electron density for the backbone, but
partial or no density for the bases. In fact, due to low elec-
tron density, the base of A -2 was not modeled in the other
related structures (1SJ3, 1VBY, 1VBZ) except for 1SJF with
cobalt hexamine bound (16). For these reasons, it has been
difficult to accurately observe the position of the upstream
nucleotides, despite the fact that their proximity to the cat-
alytic center and the reactive nucleophile influences active
site geometry.
Based on the position of the upstream nucleotides in the
original C75U-inhibited structure, a catalytic mechanism
was initially proposed that involved C75 acting as a general
base, with a hinge motion around the bond O3′-P position-
ing the O2′, the phosphate group and the N3 atom of C75
for catalysis (16). Validation outliers in this region of the
original structure have been corrected in the rebuilt struc-
ture 4PRF, with only moderate conformational changes to
the upstream nucleotides (see the Results section for de-
tails).
The 1.9A˚ structure of the deoxy-inhibited ribozyme
3NKBdoes not show significant electron density for the up-
stream nucleotide and it is, appropriately, not included in
the coordinates. The authors used the conformation of the
active site of the hammerhead ribozyme to model a plausi-
ble position for the upstream nucleotideU -1 and the scissile
phosphate in the active site of the HDV ribozyme. Based on
this model, they made structural interpretations to support
the general-acid role of C75 in the cleavage reaction (21). In
order to compare the model of the upstream nucleotides in
the mutant versus the deoxy-inhibited structures, we reca-
pitulated the model of U -1 and scissile phosphate in (21)
by superimposing residue G1 of 3NKB and the equiva-
lent residue in the hammerhead ribozyme (PDB ID: 2OEU
(22)), followed by refinement to relieve a significant steric
clash (see Supplementary Figure S4); the resulting confor-
mation fits plausibly in its surroundings and was used for
all further analyses. For the control test, modeling of the U
-1 conformation from 4PRF into 3NKB and vice-versa re-
sulted in large overlaps with the rest of the ribozyme in each
case (see Supplementary Figures S6 and S7). Figure 10 com-
pares the relative positions of the upstream nucleotides A -2
and U -1 in the rebuilt C75U-inhibited 4PRF and the U -
1 and scissile phosphate modeled into the deoxy-inhibited
3NKB, as superimposed on residue G1. The positioning at
the active site is very different in the two structures, with the
two conformations for the upstream nucleotides coming in
from nearly perpendicular directions.
The modeled position of U -1 and the scissile phosphate
into 3NKB based on the hammerhead ribozyme makes
three key interactions in the structure (Figure 11). The base
of U -1 stacks on the base of U23 (which is near crystal con-
tacts), and bothO2′ ofU -1 andOP2 (pro-Rp) of the scissile
phosphate coordinate theMg2+ in the active site. OP2 of the
scissile phosphate had been shown to be important for the
cleavage reaction (47), and this interaction of OP2 with the
coordinatedMg2+ has been confirmed by phosphorothioate
substitutions (25). This conformation also shows the poten-
tial of a hydrogen bond between the N3 atom of C75 and
the O5′ of G1; this hydrogen bond is also observed in the
rebuilt cleaved structure 4PR6. These interactions support
the general-acid role of C75 (21) and make a good binding
site for U -1, but as noted there is no clear density for it
in the 2Fo-Fc map. This lack of density was attributed ei-
ther to dynamic flexibility of the upstream nucleotides, or
to the lowered occupancy due to a fraction of the substrate
strand being cleaved in the crystal (10–50%, as reported in
Supplementary Figure S2 of (21)) in spite of the deoxy sub-
stitution. Some positive difference density is seen in the re-
gion of the modeled U -1 conformation, but there is also an
equal amount of negative difference density in that region
(see Supplementary Figure S5), limiting the probable occu-
pancy in that position to 10–20%or less. Although themod-
eled conformation seems reasonable, there is no direct crys-
tallographic evidence for it. Several active-site differences
from the cleaved 1CX0 structure have disappeared after the
rebuilding, so that although 3NKB has the very major dif-
ference of an intact metal site, it is now somewhat more sim-
ilar to the cleaved structure than previously apparent.
The rebuilt C75U-inhibited structure 4PRF has a C75U
mutation of the essential base to prevent the cleavage reac-
tion, and it has Sr2+ bound in the active site instead ofMg2+.
The scissile phosphate interacts with the metal ion at OP2
of G1, but the two interactions made by the U -1 modeled
into the deoxy-inhibited 3NKB (base-stacking on U23 and
metal ion coordination by O2′) are absent. The hydrogen
bond between N3 of C/U75 and O5′ of G1 (present in the
cleaved 4PR6 and potentially in 3NKB) is also blocked by
the scissile phosphate in 4PRF, and the 2′ hydroxyl of U -1
faces away from themetal ion. In addition, the coordination
of Sr2+ by the O4 atom of U75 is an artefact of the C75U
mutation, as an exocyclic amino group replaces theO4 atom
in the wild-type ribozyme. However, the interaction of O6
of G25 and OP2 of the scissile phosphate with the metal
ion is seen in the new model of the active site (along with
moving away O5′ of G1), making the rebuilt 4PRF struc-
ture partially suggestive of the general-acid role of C75.
These interactions are similar to the ones made by G25 and
the modeled scissile phosphate in 3NKB. A molecular dy-
namics study that used the original C75U-inhibited 1VC7
structure as a starting model (restoring the C75 residue and
the proper metal ion position) under different protonation
states of C75 reported a spontaneous rotation of the up-
stream nucleotides to support the general-acid role of C75
(19). However, our attempts to model the rotated position
into the rebuilt 4PRF active site failed. Overall, then, al-
though the C75U mutation successfully inhibited cleavage,
it is very likely that it distorted the active site, so that the up-
stream nucleotides in 4PRF do not represent the catalytic
position.
The above analysis confirms the likelihood that the C75U
mutation has distorted the active site in 4PRF, and high-
lights that the upstream nucleotide is not convincingly in-
tact in 3NKB. Therefore it seems that neither strategy to
inhibit the cleavage reaction and capture a molecular rep-
resentation of the HDV ribozyme substrate has succeeded
in achieving a good mimic of the pre-cleavage active site.
Overall, we feel that the hammerhead analogy is almost cer-
tainly correct, but reiterate that there is not yet direct evi-
dence from crystal structures.
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Figure 10. Stereo image of the upstream nucleotides (gold) in the rebuilt C75U-inhibited structure (4PRF) and the modeled upstream nucleotide U -1 and
scissile phosphate (green) in the trans-acting deoxy-inhibited structure (3NKB) are shown, as superimposed on the base of residue G1. The positions of
the corresponding metal ions in the active site are also shown. The two models for the upstream nucleotides are almost perpendicular to each other, and
the two metal positions are nearly 4A˚ apart.
Figure 11. The position of G1, modeled U -1 and the scissile phosphate
in 3NKB, based on the active site of the 2OEU hammerhead ribozyme
structure (22). Modeled U -1 stacks with U23 and the dotted lines show
the metal ion coordination by OP2 (pro-Rp) of the scissile phosphate and
O2′ of U -1 (highlighted as balls).
Role of the reverse G25:U20 wobble base pair
G25 and U20 are located in the active site and interact with
groups essential for catalysis (C/U75 and the metal ion).
In the original cleaved structure (1CX0), these bases were
aligned as for a reverse GU wobble base pair, but too far
apart for hydrogen bonding. In the original C75U-inhibited
structure (1VC7), the Hoogsteen edge of G25 interacts with
the U20 base. The rebuild for each of those structures (in in-
dependent ERRASER runs) resulted in a reverse G25:U20
wobble base pair: for 1CX0, small movements of U20 en-
abled the base-pair hydrogen bonds, whereas in 1VC7, G25
was flipped from anti to syn conformation (along with ge-
ometry and ribose pucker corrections). The reverse GU
wobble base pair positions the O6 atom on G25 to interact
with the active site metal ion in the C75U-inhibited struc-
ture, but nometal ion is bound in the cleaved structure. This
suggests, in contrast to what was proposed earlier (21), that
even though the reverse GU wobble base pair provides a
good binding site for the metal ion, the metal ion is not re-
quired for formation of the base pair.
The 1.9A˚ 3NKB structure of the deoxy-inhibited ri-
bozyme shows a reverse GU wobble base pair at this po-
sition with unambiguous electron density (21). The GU
base pair lines one side of the active site and is implicated
in binding the divalent catalytic metal ion. Several stud-
ies have found that mutating one or both these residues
leads to significant decrease in the catalytic activity of the
ribozyme, suggesting that these residues play a functional
role in the catalytic mechanism (11,24,48). Also, residues
G25 andU20 are conserved in catalytically active HDV-like
ribozymes of various species, including the human CPEB3
gene (4,6,7). Molecular dynamic simulations starting from
the original cleaved 1CX0 and the deoxy-inhibited structure
3NKB show that this reverse GU wobble base pair is stable
both in the presence and absence of the metal ion (9). How-
ever, this base pair was not observed in the simulations start-
ing from the structure 1SJ3 (one of the related structures
to 1VC7 (16)), resulting in the conclusion that the reverse
wobble base pair is not compatible with the C75U-inhibited
structures. This is incorrect as the rebuilt structure 4PRF
does have this reverse wobble base pair, and it is possible
that the simulations were not able to flip G25 (along with
the accompanying backbone changes) to make the required
hydrogen bonds.
Biochemical and nuclear magnetic resonance studies
show the presence of a reverse GU wobble base pair at this
position in the cleaved structure, but also suggest that its
formation is a post-cleavage event (48,49). This confirms
the new reverse GU wobble base pair in the rebuilt cleaved
structure, but is not consistent with the presence of this
base pair in the rebuilt C75U-inhibited structure. The 2Fo-
Fc electron density, in both the original and rebuilt C75U-
inhibited structures, is reasonable for the G25 base, but
not for its backbone; in fact, both structures show small
negative difference-density peaks for the backbone of G25
and/or neighboring residues. This, combined with the fact
of minimal and fragmentary electron density for residues
25–27, suggests that this region in the C75U-inhibited form
can adopt multiple conformations including a reverse GU
wobble base pair (modeled in the rebuilt 4PRF structure),
which is the alternative stabilized after cleavage. This degree
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of conformational flexibility should not be considered un-
expected or disturbing. However, while new methods have
enabled our current work to improve the model in this im-
portant loop region, techniques are not yet up to determin-
ing a reliable conformational ensemble through fragmen-
tary electron density.
Interpretations of alternate conformations for U23 in the
cleaved structure
The conformation of residue U23 in the original cleaved
structure 1CX0 is very different from the C75U-inhibited
1VC7 structure. This had led to the conclusion that a sig-
nificant conformational change occurs in residue U23 after
the cleavage reaction (16), due to the absence of a metal ion
in the active site to coordinate its phosphate. A close look
at the electron density near U23 led us to model a second
alternate conformation for this residue (see Results) similar
to that seen in the inhibited structures. This suggests that
release of the metal ion from the active site indeed makes
U23 more flexible, but the residue can still sample a confor-
mation similar to structures when cleavage is inhibited.
CONCLUSION
New crystallographic, conformational-search and
structure-validation tools now enable correction of
existing RNA structures and better modeling of new ones.
These tools identify significant local changes of RNA
conformation that often move atoms by many A˚ and nearly
always result in better scores for all categories of quality
measures (R, Rfree, density fit, geometry, conformation,
hydrogen bonding and all-atom sterics). For a small
percentage of individual changes the criteria disagree,
and acceptance should be based on conservative overall
scientific judgment.
In this study, we have used these new techniques to cor-
rect and improve the cleaved and the cis-acting C75U-
inhibited structures of the HDV ribozyme, which were orig-
inally solved over a decade ago. The changes include con-
formational correction of base, ribose, and backbone, fit-
ting of multiple conformations, and identification of ad-
ditional ions and waters. Our improvements, especially in
the active site, alter biological interpretations about the cat-
alyticmechanismof theHDV ribozymemade from the orig-
inal structures. Our analyses and comparisons of the rebuilt
structures with the trans-acting structure of the ribozyme
(cleavage inhibited by removing the scissile 2′ hydroxyl) re-
veal that neither of the inhibited structures are a reliable rep-
resentation of the pre-cleavage state or provide direct struc-
tural evidence for the currently accepted (26) hammerhead-
like mechanism and general-acid role for C75. Therefore,
further search for an inhibition strategy both thorough and
non-perturbing would be worthwhile. This study also high-
lights the role these new tools can play in assisting crystallo-
graphers to make well-supported biological conclusions by
helping build reliably accurate models.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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